Sahar B. Khosrovani-Van Waalwijk Van Doorn
Tilburg, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
When One Trial Is Not Enough: Lessons From Darvadstrocel Approval and Withdrawal.
Journal: Gastroenterology
Published: March 27, 2026
Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action.
Journal: Cancer treatment reviews
Published: June 10, 2025
Osimertinib with Chemotherapy in EGFR-Mutated NSCLC.
Journal: The New England journal of medicine
Published: January 31, 2024
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Journal: The Lancet. Oncology
Published: September 18, 2023
Outcome-based reimbursement in Central-Eastern Europe and Middle-East.
Journal: Frontiers in medicine
Published: May 10, 2022
The DRUG Access Protocol: access inequality and European harmonisation - Authors' reply.
Journal: The Lancet. Oncology
Published: March 30, 2022
Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.
Journal: The Lancet. Oncology
Published: November 01, 2021
Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 01, 2019
Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs.
Journal: Journal of medical economics
Published: July 24, 2015
Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: August 08, 2014
Intrauterine exposure to flavonoids modifies antioxidant status at adulthood and decreases oxidative stress-induced DNA damage.
Journal: Free radical biology & medicine
Published: June 04, 2012
Last Updated: 09/26/2026